As of Feb 10
| -0.01 / -1.52%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +515.38% increase from the last price of 0.65.
The current consensus among 1 polled investment analysts is to Buy stock in Rock Creek Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.